In the BioHarmony Drug Report Database
Vidarabine
Vira-a (vidarabine) is a small molecule pharmaceutical. Vidarabine was first approved as Vira-a on 1982-01-01. It is used to treat chickenpox, herpes simplex, herpes zoster, herpetic keratitis, and infectious keratoconjunctivitis in the USA. The pharmaceutical is active against adenosine deaminase.
Trade Name
|
Vira-a |
|---|---|
Common Name
|
vidarabine |
ChEMBL ID
|
CHEMBL1090 |
Indication
|
chickenpox, herpes simplex, herpes zoster, herpetic keratitis, infectious keratoconjunctivitis |
Drug Class
|
Antineoplastics (arabinofuranosyl derivatives) |
Image (chem structure or protein)